-
1
المؤلفون: Ingrid Bourges, Pekka Kurki, Panagiota Tsantili, Elena Wolff-Holz, Sean Barry
المساهمون: University of Helsinki, Department of Medicine
المصدر: Drugs, 81:1881-1896
Drugsمصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Postmarketing surveillance, Monoclonal antibody, Interchangeability, 03 medical and health sciences, 0302 clinical medicine, Product Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Humans, Immunologic Factors, Medicine, media_common.cataloged_instance, Pharmacology (medical), Original Research Article, European Union, APPRAISAL, European union, Intensive care medicine, Adverse effect, Biosimilar Pharmaceuticals, Drug Approval, media_common, Biosimilars, 030203 arthritis & rheumatology, Drug Substitution, business.industry, Immunogenicity, Antibodies, Monoclonal, Biosimilar, Fusion protein, 3. Good health, Therapeutic Equivalency, 317 Pharmacy, MEDICINES, 030220 oncology & carcinogenesis, Drug and Narcotic Control, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e56b8a0e4d18b12ccaa5306414cc0cdTest
https://doi.org/10.1007/s40265-021-01601-2Test -
2
المؤلفون: Maki Gouda, Antonio Ceriello, Takahiro Matsui, Hiroaki Iijima, Valeria De Nigris
المصدر: Drugs
مصطلحات موضوعية: Adult, Male, Adolescent, Postmarketing surveillance, Review Article, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Pharmacokinetics, Japan, Diabetes mellitus, Medicine, Cytochrome P-450 CYP3A, Humans, Hypoglycemic Agents, Pharmacology (medical), Drug Interactions, Teneligliptin, Canagliflozin, Child, Drug Approval, Sodium-Glucose Transporter 2 Inhibitors, Aged, Aged, 80 and over, Kidney, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Infant, Newborn, Type 2 Diabetes Mellitus, Infant, Middle Aged, medicine.disease, medicine.anatomical_structure, Diabetes Mellitus, Type 2, 030220 oncology & carcinogenesis, Child, Preschool, Oxygenases, Pyrazoles, Thiazolidines, Drug Therapy, Combination, Female, business, 030217 neurology & neurosurgery, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d59a596ba926ca12379279087dccc4Test
https://pubmed.ncbi.nlm.nih.gov/30982160Test -
3
المؤلفون: Antona J. Wagstaff, Monique P Curran
المصدر: Drugs. 64:751-760
مصطلحات موضوعية: medicine.medical_specialty, Chlormadinone Acetate, Pituitary Diseases, Postmarketing surveillance, Ethinyl Estradiol, Endometrium, Chlormadinone acetate, chemistry.chemical_compound, Papulopustular, Germany, Ethinylestradiol, Breakthrough bleeding, medicine, Humans, Pharmacology (medical), Levonorgestrel, Fallopian Tubes, health care economics and organizations, Gynecology, business.industry, Obstetrics, Contraceptives, Oral, Combined, Clinical Trials, Phase III as Topic, chemistry, Pill, Drug Therapy, Combination, Female, Controlled Clinical Trials as Topic, medicine.symptom, business, medicine.drug, Chlormadinone
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78812769c50452db984a433e56d93287Test
https://doi.org/10.2165/00003495-200464070-00005Test -
4
المؤلفون: Paul S. Lietman
المصدر: Drugs. 49:159-163
مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, business.industry, Temafloxacin, Postmarketing surveillance, Quinolones, Pharmacology, Quinolone, Antimicrobial, Anti-Infective Agents, medicine, Humans, Lomefloxacin, Pharmacology (medical), Joint Diseases, Nervous System Diseases, Intensive care medicine, Phototoxicity, Adverse effect, business, Dermatitis, Phototoxic, Fluoroquinolones, medicine.drug, Antibacterial agent
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf98cec7b08bc2efc8b6ab317638a7a9Test
https://doi.org/10.2165/00003495-199500492-00026Test -
5
المؤلفون: Thomas M McDonald, Peter Davey
المصدر: Drugs. 45:46-53
مصطلحات موضوعية: medicine.medical_specialty, Databases, Factual, Postmarketing surveillance, Quinolones, Pharmacotherapy, Anti-Infective Agents, Risk Factors, Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Humans, Medicine, Pharmacology (medical), Intensive care medicine, Antibacterial agent, business.industry, Temafloxacin, medicine.disease, Causality, Anti-Bacterial Agents, Surgery, Hospitalization, business, Adverse drug reaction, Fluoroquinolones, Decision analysis, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6685ad21802f016ce7505d78e89eceTest
https://doi.org/10.2165/00003495-199300453-00010Test -
6
المصدر: Drugs. 45:131-156
مصطلحات موضوعية: Aspirin, business.industry, Nabumetone, Anti-Inflammatory Agents, Non-Steroidal, Hemodynamics, Postmarketing surveillance, Pharmacology, medicine.disease, Ibuprofen, Butanones, Diclofenac, Tolerability, Gastric Mucosa, Rheumatic Diseases, Rheumatoid arthritis, medicine, Animals, Humans, Pharmacology (medical), Adverse effect, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c474174b5bcd7d342eb7ce4521ad7949Test
https://doi.org/10.2165/00003495-199345010-00009Test -
7
المؤلفون: Greg L. Plosker
المصدر: Drugs. 70(9)
مصطلحات موضوعية: Immunity, Herd, Male, Rotavirus, Pediatrics, medicine.medical_specialty, Postmarketing surveillance, Reoviridae, medicine.disease_cause, Antibodies, Viral, Vaccines, Attenuated, Rotavirus Infections, Herd immunity, medicine, Humans, Pharmacology (medical), Immunization Schedule, Randomized Controlled Trials as Topic, biology, business.industry, Incidence (epidemiology), Rotavirus Vaccines, Infant, biology.organism_classification, Rotavirus vaccine, Gastroenteritis, Vaccination, Europe, Treatment Outcome, Child, Preschool, Immunology, Cohort, Female, business, Intussusception
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97ead034c302cf2694510632c5db57eTest
https://pubmed.ncbi.nlm.nih.gov/20518582Test -
8
المؤلفون: Stanley Nattel, Attila S. Farkas
المصدر: Drugs. 70(5)
مصطلحات موضوعية: medicine.medical_specialty, hERG, Drug Evaluation, Preclinical, Postmarketing surveillance, Torsades de pointes, Pharmacology, QT interval, Risk Assessment, Afterdepolarization, Electrocardiography, Heart Conduction System, Predictive Value of Tests, Risk Factors, Torsades de Pointes, Internal medicine, Drug Discovery, Medicine, Repolarization, Animals, Humans, Pharmacology (medical), Proarrhythmia, biology, business.industry, Arrhythmias, Cardiac, medicine.disease, Long QT Syndrome, Drug development, Models, Animal, Cardiology, biology.protein, Biological Assay, business, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4780a3fcc2928b9285fe088cf7ef6618Test
https://pubmed.ncbi.nlm.nih.gov/20329805Test -
9
المؤلفون: Michael T. Nurmohamed
المساهمون: Rheumatology, ICaR - Ischemia and repair
المصدر: Nurmohamed, M T 2009, ' Newer biological agents in the treatment of rheumatoid arthritis do the benefits outweigh the risks? ', Drugs, vol. 69, no. 15, pp. 2035-2043 . https://doi.org/10.2165/11318290-000000000-00000Test
Drugs, 69(15), 2035-2043. Adis International Ltdمصطلحات موضوعية: musculoskeletal diseases, Oncology, Risk, medicine.medical_specialty, Immunoconjugates, medicine.medical_treatment, Postmarketing surveillance, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Drug Costs, Abatacept, Arthritis, Rheumatoid, chemistry.chemical_compound, Antibodies, Monoclonal, Murine-Derived, Tocilizumab, Drug Delivery Systems, Internal medicine, medicine, Cytokine Receptor gp130, Humans, Pharmacology (medical), Adverse effect, Randomized Controlled Trials as Topic, Biological Products, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, medicine.disease, Infliximab, TNF inhibitor, Treatment Outcome, chemistry, Rheumatoid arthritis, Antirheumatic Agents, Immunoglobulin G, Immunology, Rituximab, Drug Therapy, Combination, Immunotherapy, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4478d3f30f7240ab9fb1fd593f52f832Test
https://pubmed.ncbi.nlm.nih.gov/19791825Test -
10
المؤلفون: Paul Seale, Karen Kaye, Gordon Mallarkey, Madien Gazarian, Amanda Thomson, Tim Brighton
المصدر: Drugs. 68(12)
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, Postmarketing surveillance, Hemorrhage, Factor VIIa, Risk Assessment, law.invention, Pharmacotherapy, Randomized controlled trial, law, Medicine, Humans, Pharmacology (medical), Elective surgery, Intensive care medicine, Randomized Controlled Trials as Topic, biology, business.industry, Liver Diseases, Warfarin, Recombinant Proteins, Surgery, Clinical trial, Treatment Outcome, Recombinant factor VIIa, biology.protein, Wounds and Injuries, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16029d7a312f826daf021926c33dcfe6Test
https://pubmed.ncbi.nlm.nih.gov/18681490Test
